BDBM261841 Ethyl 2-(9-ethyl-9H-carbazol-3-yl)-1-isopropyl-1H-benzimidazole-5-carboxylate::US9708311, 92

SMILES CCOC(=O)c1ccc2n(C(C)C)c(nc2c1)-c1ccc2n(CC)c3ccccc3c2c1

InChI Key InChIKey=PMMJUEFCMGVBQK-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 261841   

TargetProstaglandin E2 receptor EP4 subtype(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM261841(Ethyl 2-(9-ethyl-9H-carbazol-3-yl)-1-isopropyl-1H-...)
Affinity DataIC50: 8.00E+3nMT: 2°CAssay Description:4 μl of a cAMP-d2/cell suspension (625000 cells/ml) were added to a test plate containing the substance solutions already initially introduced (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/31/2018
Entry Details
Go to US Patent